12. Park BW, Byun JH, Lee SG, Hah YS, Kim DR, Cho YC, et al. Evaluation of osteogenic activity and mineralization of cultured human periosteal-derived cells. J Korean Assoc Maxillofac Plast Reconstr Surg. 2006; 28:511–9.
13. Park BW, Byun JH, Ryu YM, Hah YS, Kim DR, Cho YC, et al. Correlation between vascular endothelial growth factor signaling and mineralization during osteoblastic differentiation of cultured human periosteal-derived cells. J Korean Assoc Maxillofac Plast Reconstr Surg. 2007; 29:197–205.
14. Walsh NC, Gravallese EM. Bone remodeling in rheumatic disease: a question of balance. Immunol Rev. 2010; 233:301–12.
Article
15. Li YP, Stashenko P. Proinflammatory cytokines tumor necrosis factoralpha and IL-6, but not IL-1, downregulate the osteocalcin gene promoter. J Immunol. 1992; 148:788–94.
16. Panagakos FS, Hinojosa LP, Kumar S. Formation and mineralization of extracellular matrix secreted by an immortal human osteoblastic cell line: modulation by tumor necrosis factoralpha. Inflammation. 1994; 18:267–84.
Article
17. Nanes MS. Tumor necrosis factoralpha: molecular and cellular mechanisms in skeletal pathology. Gene. 2003; 321:1–15.
18. Segal B, Rhodus NL, Patel K. Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 106:778–87.
Article
19. Ji H, Pettit A, Ohmura K, Ortiz-Lopez A, Duchatelle V, Degott C, et al. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med. 2002; 196:77–85.
20. Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest. 2005; 115:282–90.
Article
21. Zwerina J, Redlich K, Polzer K, Joosten L, Kro¨nke G, Distler J. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci USA. 2007; 104:11742–7.
Article